There are emerging data indicating that, to evade and compromise host immune surveillance, cancer cells utilize various strategies, one of which is mediated by several tumor derived soluble factors such as interleukin-10 (IL-10), transforming growth factor β (TGF β), and vascular endothelial growth factor (VEGF) [13]. The gene discussed is VEGFA; the disease is neoplasm.